Abstract: The present invention includes a method for the treatment of retinitis pigmentosa in a human that comprises administering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA). In accordance with an embodiment, the present invention provides a method for the treatment of retinitis pigmentosa in an animal that comprises administering to the animal a therapeutically effective amount of N-acetylcystein amide (NACA).

Abstract: The present invention includes a method for the treatment of retinitis pigmentosa in a human that comprises adminisering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA). In accordance with an embodiment, the present invention provides a method for the treatment of retinitis pigmentosa in an animal that comprises administering to the animal a therapeutically effective amount of N-acetylcystein amide (NACA).

Abstract: The present inventions provide methods of manufacturing methods for case metallic materials for munitions that have high enthalpic energy release and controlled fragmentation and breakup enabling fragment speeds up to twice what is otherwise possible in explosively driven metal systems, and munitions made by such methods. Embodiments of the invention involve the thixotropic processing of energetic materials such as aluminum together with high density materials such as tantalum or tungsten to achieve material microstructures with a bulk density equivalent to steel, but with the energy release potential of materials such as finely dispersed aluminum powders.

Abstract: The present inventions provide methods of manufacturing methods for case metallic materials for munitions that have high enthalpic energy release and controlled fragmentation and breakup enabling fragment speeds up to twice what is otherwise possible in explosively driven metal systems, and munitions made by such methods. Embodiments of the invention involve the thixotropic processing of energetic materials such as aluminum together with high density materials such as tantalum or tungsten to achieve material microstructures with a bulk density equivalent to steel, but with the energy release potential of materials such as finely dispersed aluminum powders.

Abstract: The invention provides methods and formulations for treating and preventing acute coronary syndromes. The methods of the instant invention provide safe and effective doses of an Apolipoprotein A-I Milano: phospholipid complex to reduce and stabilize atherosclerotic plaque. Pharmaceutical formulations of the Apo A-I Milano:phospholipid complexes are also provided.

Abstract: The invention provides methods and formulations for treating and preventing acute coronary syndromes. The methods of the instant invention provide safe and effective doses of an Apolipoprotein A-I Milano:phospholipid complex to reduce and stabilize atherosclerotic plaque. Pharmaceutical formulations of the Apo A-I Milano:phospholipid complexes are also provided.

Abstract: A projectile formed from dissimilar materials. The projectile includes a metallurgical interlayer that joins the dissimilar materials together. The metallurgical interlayer also matches the shock impedance of the two materials to prevent delamination during launch and during impact.

Abstract: A delay-locked loop, including a phase detector configured to receive two signals, one of the signals being delayed relative to the other of the signals, the phase detector having an UP output and a DOWN output. The delay-locked loop also includes a charge pump system operatively coupled with the phase detector, the charge pump system including (1) a charge pump configured to be responsive to assertion of actuating signals from the UP output and the DOWN output so as to control pumping of charge from the charge pump system, such pumped charge being usable to control a delay line carrying one of the two signals, so as to control relative delay occurring between the two signals; and (2) a feedback control loop configured to dynamically adjust at least one bias signal at the charge pump so as to minimize net charge pumped from the charge pump system during simultaneous assertion of actuating signals from the UP output and the DOWN output.

Abstract: The invention provides methods and formulations for treating and preventing acute coronary syndromes. The methods of the instant invention provide safe and effective doses of an Apolipoprotein A-I Milano: phospholipid complex to reduce and stabilize atherosclerotic plaque. Pharmaceutical formulations of the Apo A-I Milano:phospholipid complexes are also provided.

Abstract: Disclosed herein are methods for treating and preventing inflammation and inflammation-associated diseases by co-administering to a patient in need thereof a dialkyl ether, substituted alkyl, substituted aryl-alkyl, substituted dialkyl thioether, substituted dialkyl ketone, substituted-alkyl, or a pharmaceutically acceptable salt of said dialkyl ether, substituted alkyl, substituted alkyl-alkyl, substituted dialkyl thioether, substituted dialkyl ketone, or substituted-alkyl, and a statin, or a pharmaceutically acceptable salt of said statin.